Akèy › Kansè pwostat › Distrik Columbia › Washington
Etid klinik pou Kansè pwostat nan Washington, DC
38 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
The Vanguard Study: Testing a New Way to Screen for Cancer
Ap rekriteVolontè an sante akeyi
- Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Ap rekriteFaz 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Collection of Blood From Patients With Prostate Cancer
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Precision-Based Genomics in Prostate Cancer
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Collection of Blood From Patients With Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Ap rekriteFaz 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Ap rekriteFaz 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Ap rekriteFaz 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Ap rekriteFaz 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · 11 mi lwen
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Men at High Genetic Risk for Prostate Cancer
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Ap rekrite
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
Ap rekriteFaz 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Ap rekriteFaz 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · 7 mi lwen
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Ap rekriteFaz 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Ap rekriteFaz 1
- Maryland Oncology Hematology, Silver Spring · 7 mi lwen
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Ap rekriteFaz 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Ap rekrite
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
Ap rekriteFaz 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Ap rekriteFaz 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Ap rekriteVolontè an sante akeyi
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · 7 mi lwen
- Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Ap rekriteFaz 3
- George Washington University Medical Center, Washington D.C.
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN43 etid
- Seattle, WA42 etid
- Dallas, TX36 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
- Limfom23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.